Novel Coumarin Derivatives Containing Oxazole/Isoxazole/Pyrazole Groups as Antifungal Agents: Design, Synthesis, Quantitative Structure–Activity Relationships, and Preliminary Mechanistic Insights
Journal of Agricultural and Food Chemistry · 2026
DOI: 10.1021/acs.jafc.6c10905 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Agricultural and Food Chemistry, 2026. Verfasst von Peng Dai und 9 weiteren Autor:innen. Beteiligte Einrichtung: Anhui Provincial Key Laboratory of Advanced Catalysis and Energy Materials, Anhui Key Laboratory of Optoelectronic Magnetic Functional Complex and Na…. Hauptthemen laut MEDLINE: Coumarins, Isoxazoles, Pyrazoles, Fungicides, Industrial. Die Arbeit nennt 37 Literaturangaben. Gefördert von: Basic Research Program of Jiangsu Province, Fundamental Research Funds for the Central Universities.
Abstract (Originalsprache)
Plant pathogenic fungi pose a significant threat to global crop productivity and food security. Herein, we report the design and synthesis of 55 coumarin–oxazole, −isoxazole, and −pyrazole hybrids as novel antifungal agents. Most derivatives exhibited notable potency, with C1, C4, and C5 showing strong activity against Rhizoctonia solani (EC50 = 6.4, 5.9, and 8.6 μg/mL), while C2 displayed superior activity against Alternaria solani (EC50 = 4.5 μg/mL). Structure–activity relationship and density functional theory (DFT) analyses revealed that the pyrazole heterocycle and electron-withdrawing substituents were key determinants of potency. Mechanistic studies on C4 demonstrated that it induces morphological damage, mitochondrial dysfunction (reactive oxygen species (ROS) overproduction, mitochondrial membrane potential (MMP) dissipation), cell membrane disruption (propidium iodide (PI) fluorescence, nucleic acid leakage, malondialdehyde (MDA) elevation, increased conductivity), and interferes with ergosterol-associated pathways. These findings establish coumarin–azole hybrids as promising leads for antifungal development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Anhui Provincial Key Laboratory of Advanced Catalysis and Energy Materials, Anhui Key Laboratory of Optoelectronic Magnetic Functional Complex and Nano Complex, School of Chemistry and Chemical Engineering, Anqing Norma…
- Chengdu Institute of Biology, Chinese Academy of Sciences, Chengdu610213, China.
- School of Chemistry and Chemical Engineering, Hainan University, Haikou570228, China.
- Xinghuo Industrial Park, High-tech Industrial Development Zone, Yijiang District, Wuhu, Anhui241002, China.
- Jiangsu Key Laboratory of Pesticide Science, College of Sciences, Nanjing Agricultural University, Nanjing210095, China.
ORCID-Profile: Chunyin Ye, Weihua Zhang
Förderung
- Basic Research Program of Jiangsu Province
- Fundamental Research Funds for the Central Universities
Zitieren
APA
Dai, P., Hong, Y., Zhang, Y., Sun, W., Liu, K., Liang, W., Ye, C., Zhou, Y., Qin, Y., & Zhang, W. (2026). Novel Coumarin Derivatives Containing Oxazole/Isoxazole/Pyrazole Groups as Antifungal Agents: Design, Synthesis, Quantitative Structure–Activity Relationships, and Preliminary Mechanistic Insights. Journal of Agricultural and Food Chemistry. https://doi.org/10.1021/acs.jafc.6c10905
Vancouver
Dai P, Hong Y, Zhang Y, Sun W, Liu K, Liang W, et al. Novel Coumarin Derivatives Containing Oxazole/Isoxazole/Pyrazole Groups as Antifungal Agents: Design, Synthesis, Quantitative Structure–Activity Relationships, and Preliminary Mechanistic Insights. Journal of Agricultural and Food Chemistry. 2026. doi:10.1021/acs.jafc.6c10905
BibTeX
@article{Dai2026,
author = {Dai, Peng and Hong, Yang and Zhang, Yue and Sun, Weipeng and Liu, Keke and Liang, Wanyu and Ye, Chunyin and Zhou, Yujie and Qin, Yinghan and Zhang, Weihua},
title = {Novel Coumarin Derivatives Containing Oxazole/Isoxazole/Pyrazole Groups as Antifungal Agents: Design, Synthesis, Quantitative Structure–Activity Relationships, and Preliminary Mechanistic Insights},
journal = {Journal of Agricultural and Food Chemistry},
year = {2026},
doi = {10.1021/acs.jafc.6c10905}
}
EUVIMED